• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pearl Therapeutics, Inc. - Product Pipeline Review - Q4 2010 Product Image

Pearl Therapeutics, Inc. - Product Pipeline Review - Q4 2010

  • Published: November 2010
  • Region: Global
  • 37 pages
  • GlobalData

Pearl Therapeutics, Inc. – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Pearl Therapeutics, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Pearl Therapeutics, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pearl Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination READ MORE >



List of Tables
List of Figures
Pearl Therapeutics, Inc. Snapshot
Pearl Therapeutics, Inc. Overview
Key Information
Key Facts
Pearl Therapeutics, Inc. – Research and Development Overview
Key Therapeutic Areas
Pearl Therapeutics, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pearl Therapeutics, Inc. – Pipeline Products Glance
Pearl Therapeutics, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Pearl Therapeutics, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Pearl Therapeutics, Inc. – Drug Profiles
PT001
Product Description
Mechanism of Action
R&D Progress
PT003
Product Description
Mechanism of Action
R&D Progress
PT005
Product Description
Mechanism of Action
R&D Progress
PT002 + PT009
Product Description
Mechanism of Action
R&D Progress
PT010
Product Description
Mechanism of Action
R&D Progress
Pearl Therapeutics, Inc. – Pipeline Analysis
Pearl Therapeutics, Inc. – Pipeline Products by Therapeutic Class
Pearl Therapeutics, Inc. Pipeline Products By Target
Pearl Therapeutics, Inc. – Pipeline Products by Route of Administration
Pearl Therapeutics, Inc. – Recent Pipeline Updates
Pearl Therapeutics, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
May 18, 2010: PEARL Presents Encouraging Data For PT003 For Treatment Of Patients With COPD
May 05, 2010: Pearl Therapeutics To Present Data On Bronchodilator Combination Therapeutic For COPD At The American Thoracic Society Annual Meeting
Mar 29, 2010: Pearl Therapeutics Announces Positive Results From Phase I Trial Of PT003 For Treatment Of COPD
Feb 01, 2010: Pearl Therapeutics Raises $15 Million To Advance PT003, Lama/Laba Combination Bronchodilator For COPD, Into Phase 2b Study
Jan 06, 2010: Pearl Therapeutics Announces Positive Results From Phase 2a Trial Of Glycopyrrolate Inhalation Aerosol, PT001 In Chronic Obstructive Pulmonary Disease
Jan 04, 2010: Pearl Therapeutics Announces Positive Results From Phase 2A Trial Of Formoterol Inhalation Aerosol In Chronic Obstructive Pulmonary Disease
Financial Deals Landscape
Pearl Therapeutics, Inc., Deals Summary, 2004 to 2010
Pearl Therapeutics, Inc. Detailed Deal Summary
Venture Financing
Pearl Therapeutics Secures $15 Million In Series C Venture Financing
Pearl Therapeutics Secures Additional $18 Million In Series A Financing
Pearl Therapeutics Secures $15.5 Million In Series A Financing
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS